Peter Van der Velden's most recent trade in Edesa Biotech Inc was a trade of 139,450 Common share done at an average price of $2.6 . Disclosure was reported to the exchange on Jan. 9, 2023.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Edesa Biotech Inc | Peter Van der Velden | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 2.63 per share. | 09 Jan 2023 | 139,450 | 1,625,133 (18%) | 1% | 2.6 | 367,395 | Common share |
Edesa Biotech Inc | Peter Van der Velden | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 2.66 per share. | 09 Jan 2023 | 132,845 | 1,764,583 (19%) | 1% | 2.7 | 353,647 | Common share |
Edesa Biotech Inc | Peter Van der Velden | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 2.63 per share. | 09 Jan 2023 | 12,895 | 150,275 (1%) | 0% | 2.6 | 33,973 | Common share |
Edesa Biotech Inc | Peter Van der Velden | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 2.66 per share. | 09 Jan 2023 | 12,284 | 163,170 (1%) | 0% | 2.7 | 32,701 | Common share |
Edesa Biotech Inc | Peter Van der Velden | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Apr 2021 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
Edesa Biotech Inc | Peter Van der Velden | Director, Ten Percent Owner | 02 Nov 2020 | 64,362 | 1,897,428 (21%) | 0% | 4 | 257,448 | Common Shares | |
Edesa Biotech Inc | Peter Van der Velden | Director, Ten Percent Owner | 02 Nov 2020 | 64,362 | 0 | - | - | Common Share Warrants (Right to Buy) | ||
Edesa Biotech Inc | Peter Van der Velden | Director, Ten Percent Owner | 02 Nov 2020 | 5,952 | 0 | - | - | Common Share Warrants (Right to Buy) | ||
Edesa Biotech Inc | Peter Van der Velden | Director, Ten Percent Owner | 02 Nov 2020 | 5,952 | 175,454 (1%) | 0% | 4 | 23,808 | Common Shares | |
Edesa Biotech Inc | Peter Van der Velden | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Oct 2020 | 20,000 | 20,000 | - | - | Stock option (right to buy) |